Short answer
LifeMD, Inc. (LFMD) filed an 8-K current report with the SEC on March 18, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 8.01 (Other Events). Item 5.02 covers officer/director changes with implications for company leadership.
LifeMD, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Item 5.02 covers officer/director changes with implications for company leadership
- This filing lacks specific details on personnel changes or compensation terms
- References agreements filed as exhibits for full context on rights and obligations
- Investors should review exhibits to assess any governance or succession impact
Item 8.01 · Other Events
- CFO Marc Benathen resigned; Atul Kavthekar appointed new CFO, signaling potential strategic or financial leadership shift
- Jessica Friedeman promoted to Chief Business Officer, likely to influence business development and corporate growth strategies
- Chris Pisano promoted to Chief Marketing Officer, indicating a focus on marketing and brand positioning initiatives
- Executive changes may impact company’s operational priorities and investor confidence in leadership stability
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other LifeMD, Inc. 8-K filings
Get the next LFMD 8-K as it lands
Follow LFMD for push alerts, or ask the research agent what this filing means.